APA (7th ed.) Citation

Lu-Qi Cao, Lu-Qi Cao, Haidong Sun, Yuhao Xie, Harsh Patel, Letao Bo, . . . Zhe-Sheng Chen. (2024). Therapeutic evolution in HR+/HER2- breast cancer: From targeted therapy to endocrine therapy. Frontiers Media S.A..

Chicago Style (17th ed.) Citation

Lu-Qi Cao, Lu-Qi Cao, Haidong Sun, Yuhao Xie, Harsh Patel, Letao Bo, Hanli Lin, Zhe-Sheng Chen, and Zhe-Sheng Chen. Therapeutic Evolution in HR+/HER2- Breast Cancer: From Targeted Therapy to Endocrine Therapy. Frontiers Media S.A., 2024.

MLA (9th ed.) Citation

Lu-Qi Cao, et al. Therapeutic Evolution in HR+/HER2- Breast Cancer: From Targeted Therapy to Endocrine Therapy. Frontiers Media S.A., 2024.